A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2002
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254111A1 Novel vitamin d analogues
11/06/2002	EP1254108A1 Gamma-secretase inhibitors
11/06/2002	EP1253932A2 Botulinum toxin pharmaceutical compositions
11/06/2002	EP1253931A2 Utilization of protein kinase inhibitor alpha
11/06/2002	EP1253926A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1253918A2 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
11/06/2002	EP1253917A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
11/06/2002	EP1253915A1 Method for treating stress with a precursor of serotonin
11/06/2002	EP1253853A1 Method for classifying and treating physiologic brain imbalances using quantitative eeg
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP0981349B1 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases
11/06/2002	EP0923576B1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
11/06/2002	EP0898566B1 Substituted benzylamines and their use for the treatment of depression
11/06/2002	EP0800528B1 Peptide and peptide analog protease inhibitors
11/06/2002	EP0784476B1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and optionally a vitamin b 12 compound
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378550A Partial or full A1 agonists-N6 heterocyclic 5' thio substituted adenosine devivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378471A Dual adhesive transdermal drug delivery system
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378453A Neuropathy remedies
11/06/2002	CN1378452A Orally disintegrating composition containing mirtazapine
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002	CN1377690A Medicine for curing neurosism and preparing method and use
11/06/2002	CN1377683A Medicinal formula for curing sciatic nerve disease and protrusion of lumbar intervertebral disc
11/06/2002	CN1377668A Pure traditional Chinese medicinal preparation for curing child's epilepsy disease and its preparing method
11/06/2002	CN1377649A Use of hydroxy asiaticoside for preparingm edicine for curing depression
11/06/2002	CN1377586A Sobering-up and drunkenness-preventing liver protective beverage containing dehydrogenase
11/06/2002	CN1093860C Pyridazino-[4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
11/06/2002	CN1093859C Novel indole-2,3-dione-3-oxime derivatives
11/06/2002	CN1093857C New piperazine and piperidine compounds
11/06/2002	CN1093767C Protein kinase C inhibitors
11/06/2002	CN1093762C Aqueous suspension of 9-hydroxyrisperidone fatty and esters
11/06/2002	CA2408401A1 Compositions containing folic acid and reduced folate
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476078 Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
11/05/2002	US6476051 For therapy of psychosis, acute mania, mild anxiety states, or depression in combination with psychotic episodes
11/05/2002	US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/05/2002	US6476042 Combination therapy for the treatment of migraine
11/05/2002	US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002	US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476019 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6476007 Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold
11/05/2002	US6476001 Facilitation of repair of neural injury with CM101/GBS toxin
11/05/2002	US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002	US6475494 In an oral dosage form, providing a combination product analgesically effective when administered orally, but which is aversive in addicts at the same dose or higher dose than prescribed; prevention of drug abuse, drug dependency
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	CA2359810C Process for the preparation of pure citalopram
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/02/2002	CA2384344A1 4-(2-pyridyl)piperizines having 5ht7 receptor agonist activity
11/01/2002	CA2384227A1 Combination treatment for anxiety and depression
11/01/2002	CA2345864A1 Androgen-mediated neuroprotection and its use for prevention, treatment and study of neural disease
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086108A1 Method for differentiating mesenchymal stem cells into neural cells
10/31/2002	WO2002086106A1 Method and culture medium for producing neural cells expressing tyrosine hydroxylase
10/31/2002	WO2002086105A1 Delivery of polynucleotide agents to the central nervous sysstem
10/31/2002	WO2002086104A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086079A2 T1r3 a novel taste receptor
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085912A1 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENE
10/31/2002	WO2002085911A1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 1,4-DIOXINO[2,3-b]PYRIDINE
10/31/2002	WO2002085910A1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085903A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/31/2002	WO2002085901A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
10/31/2002	WO2002085900A1 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-ht1a antagonists
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085896A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
10/31/2002	WO2002085892A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	WO2002085890A1 Benzimidazolone derivatives
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same

1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 1833